LOS ANGELES (AP) — LOS ANGELES (AP) — Puma Biotechnology Inc. (PBYI) on Thursday reported third-quarter profit of $20.3 million.
The Los Angeles-based company said it had profit of 41 cents per share. Earnings, adjusted for stock option expense, were 45 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 35 cents per share.
The biopharmaceutical company posted revenue of $80.5 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
